Analyzing circulating IL-17 levels and combining these results with genetic studies and miRNA-mediated regulatory mechanisms in kidney transplant patients may help us understand the immunological mechanisms associated with inflammation in patients with kidney disease. The gene discussed is IL17A; the disease is kidney disorder.